178 related articles for article (PubMed ID: 29162880)
1. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.
Wang CQ; Tang CH; Wang Y; Jin L; Wang Q; Li X; Hu GN; Huang BF; Zhao YM; Su CM
Sci Rep; 2017 Nov; 7(1):15887. PubMed ID: 29162880
[TBL] [Abstract][Full Text] [Related]
2. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.
Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
[TBL] [Abstract][Full Text] [Related]
3. The association of FSCN1 (rs852479, rs1640233) and HOTAIR (rs920778) polymorphisms with the risk of breast cancer in Egyptian women.
Galal ER; Abdelhakam DA; Ahmed LK; Elhusseny Y; Sayed SEP; Eltaweel NH
Mol Biol Rep; 2024 Apr; 51(1):495. PubMed ID: 38587571
[TBL] [Abstract][Full Text] [Related]
4.
Huang BF; Tzeng HE; Chen PC; Wang CQ; Su CM; Wang Y; Hu GN; Zhao YM; Wang Q; Tang CH
Int J Med Sci; 2018; 15(6):580-586. PubMed ID: 29725248
[TBL] [Abstract][Full Text] [Related]
5. Correlation between LSP1 polymorphisms and the susceptibility to breast cancer.
Chen H; Qi X; Qiu P; Zhao J
Int J Clin Exp Pathol; 2015; 8(5):5798-802. PubMed ID: 26191300
[TBL] [Abstract][Full Text] [Related]
6. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal Focal Adhesion Proteins Fascin-1 and Paxillin Are Predictors of Malignant Progression and Poor Prognosis in Human Breast Cancer.
Omran OM; Al Sheeha M
J Environ Pathol Toxicol Oncol; 2015; 34(3):201-12. PubMed ID: 26349603
[TBL] [Abstract][Full Text] [Related]
8. EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
Wang CQ; Li Y; Huang BF; Zhao YM; Yuan H; Guo D; Su CM; Hu GN; Wang Q; Long T; Wang Y; Tang CH; Li X
Sci Rep; 2017 Nov; 7(1):15654. PubMed ID: 29142206
[TBL] [Abstract][Full Text] [Related]
9. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
10. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
[TBL] [Abstract][Full Text] [Related]
11. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
12. Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians.
Rizk SM; Shahin NN; Shaker OG
PLoS One; 2016; 11(3):e0151901. PubMed ID: 26999517
[TBL] [Abstract][Full Text] [Related]
13. The role and regulatory mechanism of FSCN1 in breast tumorigenesis and progression.
Chang D; Liu XX; Liu R; Sun JW
Yi Chuan; 2023 Feb; 45(2):115-127. PubMed ID: 36927659
[TBL] [Abstract][Full Text] [Related]
14. N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
He G; Li M; Fang L; Xu L; Huang X; Zheng L; Yang L; Luo W; Cai Y; Ma W; Liang C; Yin Y
Oncol Rep; 2020 Nov; 44(5):2265-2274. PubMed ID: 33000273
[TBL] [Abstract][Full Text] [Related]
15. Genetic association of deleted in colorectal carcinoma variants with breast cancer risk: A case-control study.
Liu X; Wang X; Fu SW; Wang M; Kang H; Guan H; Zhang S; Ma X; Lin S; Liu K; Feng Y; Dai C; Dai Z
Oncotarget; 2016 May; 7(22):32765-73. PubMed ID: 27127179
[TBL] [Abstract][Full Text] [Related]
16. Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.
Forma E; Brzeziańska E; Krześlak A; Chwatko G; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
Mol Biol Rep; 2013 May; 40(5):3493-502. PubMed ID: 23277395
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
Xu W; Chang J; Du X; Hou J
Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
[TBL] [Abstract][Full Text] [Related]
18. Correlation between
Hu GN; Tzeng HE; Chen PC; Wang CQ; Zhao YM; Wang Y; Su CM; Tang CH
Int J Med Sci; 2018; 15(11):1179-1186. PubMed ID: 30123055
[TBL] [Abstract][Full Text] [Related]
19. Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas.
Mahdiannasser M; Haghpanah V; Damavandi E; Kabuli M; Tavangar SM; Larijani B; Ghadami M
Mol Biol Rep; 2020 Mar; 47(3):2161-2169. PubMed ID: 32072403
[TBL] [Abstract][Full Text] [Related]
20. FSCN1 Promotes Epithelial-Mesenchymal Transition Through Increasing Snail1 in Ovarian Cancer Cells.
Li J; Zhang S; Pei M; Wu L; Liu Y; Li H; Lu J; Li X
Cell Physiol Biochem; 2018; 49(5):1766-1777. PubMed ID: 30231243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
